Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Pandion Therapeutics, Inc. (PAND)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-20 | Sep-30-20 | Jun-30-20 | Mar-31-20 | Dec-31-19 |
| | 10-K | 10-Q | 10-Q | S-1/A | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 299.4% | 355.6% | 596.2% | 1198.9% | 118.1% |
| Gross profit | -199.4% | -255.6% | -496.2% | -1098.9% | -18.1% |
| Research and development | 348.1% | 336.1% | 437.6% | | 140.0% |
| General and administrative | 209.8% | 207.3% | 275.2% | 478.1% | 73.7% |
| Depreciation | 6.6% | 6.0% | 7.7% | | 2.6% |
| EBIT | -692.6% | -722.1% | -1080.1% | -1994.8% | -293.0% |
| Pre-tax income | -691.6% | -719.0% | -1067.2% | -1962.3% | -288.2% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -453.0% | -451.2% | -627.5% | -988.6% | -204.3% |
|